These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Nishimori I, Vullo D, Innocenti A, Scozzafava A, Mastrolorenzo A, Supuran CT. Bioorg Med Chem Lett; 2005 Sep 01; 15(17):3828-33. PubMed ID: 16039848 [Abstract] [Full Text] [Related]
27. QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. Singh S, Khadikar PV, Scozzafava A, Supuran CT. J Enzyme Inhib Med Chem; 2009 Apr 01; 24(2):337-49. PubMed ID: 18830873 [Abstract] [Full Text] [Related]
28. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII. Brzozowski Z, Sławiński J, Vullo D, Supuran CT. Eur J Med Chem; 2012 Oct 01; 56():282-91. PubMed ID: 22910138 [Abstract] [Full Text] [Related]
31. Carbonic anhydrase inhibitors: inhibition of cytosolic carbonic anhydrase isozymes II and VII with simple aromatic sulfonamides and some azo dyes. Carta F, Pothen B, Maresca A, Tiwari M, Singh V, Supuran CT. Chem Biol Drug Des; 2009 Aug 01; 74(2):196-202. PubMed ID: 19549076 [Abstract] [Full Text] [Related]
33. New series of sulfonamides containing amino acid moiety act as effective and selective inhibitors of tumor-associated carbonic anhydrase XII. Ceruso M, Bragagni M, AlOthman Z, Osman SM, Supuran CT. J Enzyme Inhib Med Chem; 2015 Jun 01; 30(3):430-4. PubMed ID: 25089707 [Abstract] [Full Text] [Related]
34. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices. Melagraki G, Afantitis A, Sarimveis H, Igglessi-Markopoulou O, Supuran CT. Bioorg Med Chem; 2006 Feb 15; 14(4):1108-14. PubMed ID: 16213737 [Abstract] [Full Text] [Related]
35. Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. Sławiński J, Pogorzelska A, Żołnowska B, Brożewicz K, Vullo D, Supuran CT. Eur J Med Chem; 2014 Jul 23; 82():47-55. PubMed ID: 24871996 [Abstract] [Full Text] [Related]
37. Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides. Pastorekova S, Vullo D, Casini A, Scozzafava A, Pastorek J, Nishimori I, Supuran CT. J Enzyme Inhib Med Chem; 2005 Jun 23; 20(3):211-7. PubMed ID: 16119190 [Abstract] [Full Text] [Related]
38. A physically interpretable quantum-theoretic QSAR for some carbonic anhydrase inhibitors with diverse aromatic rings, obtained by a new QSAR procedure. Clare BW, Supuran CT. Bioorg Med Chem; 2005 Mar 15; 13(6):2197-211. PubMed ID: 15727872 [Abstract] [Full Text] [Related]
39. New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II. Carta F, Vullo D, Maresca A, Scozzafava A, Supuran CT. Bioorg Med Chem Lett; 2012 Mar 15; 22(6):2182-5. PubMed ID: 22365761 [Abstract] [Full Text] [Related]
40. Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. Innocenti A, Hilvo M, Scozzafava A, Parkkila S, Supuran CT. Bioorg Med Chem Lett; 2008 Jun 15; 18(12):3593-6. PubMed ID: 18501600 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]